The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder

NCT06115603 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder

Interventions

DRUG: Cannabigerol
OTHER: Placebo

Sponsor

University of Arkansas, Fayetteville